David Phillips , Marianne J. Ellis , Jan Frayne , Sandhya Moise
{"title":"动态培养条件对流化床生物反应器内红系祖细胞系产生的影响","authors":"David Phillips , Marianne J. Ellis , Jan Frayne , Sandhya Moise","doi":"10.1016/j.bej.2025.109936","DOIUrl":null,"url":null,"abstract":"<div><div>Red blood cells (RBCs) are an essential therapeutic resource; however, insufficient supply and risks of blood-borne infections drive the need for alternative sources. The Bristol Erythroid Lineage – Adult (BEL-A) erythroid progenitor cell line provides a new source for the indefinite production of cultured RBCs, but efficient and scalable bioprocessing strategies are yet to be established. Fluidised bed bioreactors (FBBs), with their low-shear environments and high mass transfer capabilities, can support high-density cultures, particularly at large scales, offering a promising manufacturing platform for BEL-A expansion. However, their optimal operating conditions and effects on BEL-A cell have yet to be defined. Using a design of experiments statistical approach, we systematically investigated how dynamic culture conditions impact BEL-A proliferation within FBBs. A lower media perfusion velocity, reduced initial cell seeding number, and a higher cell density (cells/mL) enhanced cellular proliferation. We demonstrate that FBB culture achieved productivity comparable to static culture whilst offering scalability and reduced manual handling. Importantly, no spontaneous differentiation of BEL-A cells was observed, confirming the system’s suitability for maintaining progenitor cell characteristics. This study is the first to demonstrate the feasibility of FBBs for mammalian single-cell suspension culture, using BEL-A as a model system. Furthermore, our work represents a critical step towards the clinical-scale manufacture of BEL-A cells and unlocking their therapeutic potential as a source of cultured RBCs.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"225 ","pages":"Article 109936"},"PeriodicalIF":3.7000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of dynamic culture conditions on the production of an erythroid progenitor cell line within fluidised bed bioreactors\",\"authors\":\"David Phillips , Marianne J. Ellis , Jan Frayne , Sandhya Moise\",\"doi\":\"10.1016/j.bej.2025.109936\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Red blood cells (RBCs) are an essential therapeutic resource; however, insufficient supply and risks of blood-borne infections drive the need for alternative sources. The Bristol Erythroid Lineage – Adult (BEL-A) erythroid progenitor cell line provides a new source for the indefinite production of cultured RBCs, but efficient and scalable bioprocessing strategies are yet to be established. Fluidised bed bioreactors (FBBs), with their low-shear environments and high mass transfer capabilities, can support high-density cultures, particularly at large scales, offering a promising manufacturing platform for BEL-A expansion. However, their optimal operating conditions and effects on BEL-A cell have yet to be defined. Using a design of experiments statistical approach, we systematically investigated how dynamic culture conditions impact BEL-A proliferation within FBBs. A lower media perfusion velocity, reduced initial cell seeding number, and a higher cell density (cells/mL) enhanced cellular proliferation. We demonstrate that FBB culture achieved productivity comparable to static culture whilst offering scalability and reduced manual handling. Importantly, no spontaneous differentiation of BEL-A cells was observed, confirming the system’s suitability for maintaining progenitor cell characteristics. This study is the first to demonstrate the feasibility of FBBs for mammalian single-cell suspension culture, using BEL-A as a model system. Furthermore, our work represents a critical step towards the clinical-scale manufacture of BEL-A cells and unlocking their therapeutic potential as a source of cultured RBCs.</div></div>\",\"PeriodicalId\":8766,\"journal\":{\"name\":\"Biochemical Engineering Journal\",\"volume\":\"225 \",\"pages\":\"Article 109936\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemical Engineering Journal\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1369703X25003109\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X25003109","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Effect of dynamic culture conditions on the production of an erythroid progenitor cell line within fluidised bed bioreactors
Red blood cells (RBCs) are an essential therapeutic resource; however, insufficient supply and risks of blood-borne infections drive the need for alternative sources. The Bristol Erythroid Lineage – Adult (BEL-A) erythroid progenitor cell line provides a new source for the indefinite production of cultured RBCs, but efficient and scalable bioprocessing strategies are yet to be established. Fluidised bed bioreactors (FBBs), with their low-shear environments and high mass transfer capabilities, can support high-density cultures, particularly at large scales, offering a promising manufacturing platform for BEL-A expansion. However, their optimal operating conditions and effects on BEL-A cell have yet to be defined. Using a design of experiments statistical approach, we systematically investigated how dynamic culture conditions impact BEL-A proliferation within FBBs. A lower media perfusion velocity, reduced initial cell seeding number, and a higher cell density (cells/mL) enhanced cellular proliferation. We demonstrate that FBB culture achieved productivity comparable to static culture whilst offering scalability and reduced manual handling. Importantly, no spontaneous differentiation of BEL-A cells was observed, confirming the system’s suitability for maintaining progenitor cell characteristics. This study is the first to demonstrate the feasibility of FBBs for mammalian single-cell suspension culture, using BEL-A as a model system. Furthermore, our work represents a critical step towards the clinical-scale manufacture of BEL-A cells and unlocking their therapeutic potential as a source of cultured RBCs.
期刊介绍:
The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.
The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:
Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics
Biosensors and Biodevices including biofabrication and novel fuel cell development
Bioseparations including scale-up and protein refolding/renaturation
Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells
Bioreactor Systems including characterization, optimization and scale-up
Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization
Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals
Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release
Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites
Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation
Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis
Protein Engineering including enzyme engineering and directed evolution.